Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccines01:21

Vaccines

86
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
86
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.9K
4.9K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence.

Emerging microbes & infections·2023
Same author

Automated machine learning-based model for the prediction of delirium in patients after surgery for degenerative spinal disease.

CNS neuroscience & therapeutics·2022
Same author

A Label-free aptasensor based on Aptamer/NH<sub>2</sub> Janus particles for ultrasensitive electrochemical detection of Ochratoxin A.

Talanta·2019
Same author

Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.

Oncology reports·2013
Same author

[Study on the detoxification of alcohol extracts from orientvine and its effective component on withdrawal syndromes of morphine].

Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials·2009
Same author

Physiological and pathological actions of calpains in glutamatergic neurons.

Science signaling·2008

Related Experiment Video

Updated: Apr 28, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.6K

Enhanced Th1 Cellular Immunity Induced by an RSV-F mRNA Vaccine Rationally Designed Using NLP Algorithms.

Zhi-Wu Xia1,2, Qi Tang3, Jun-Jie Pan3

  • 1College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.

Vaccines
|April 27, 2026
PubMed
Summary
This summary is machine-generated.

A new mRNA vaccine for Respiratory Syncytial Virus (RSV) shows promise. Optimized for stability and efficacy, it induced strong immune responses in mice, suggesting potential for a safe and effective RSV vaccine.

Keywords:
T-cell immunityimmunogenicity evaluationmRNA vaccinememory T cellsrespiratory syncytial virus

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.3K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.3K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.1K

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Immunology

Background:

  • Respiratory Syncytial Virus (RSV) causes significant global disease burden, particularly in vulnerable populations.
  • Limited preventive options highlight the urgent need for effective and safe vaccines.
  • Developing an RSV vaccine is a critical public health priority.

Purpose of the Study:

  • To design and develop a novel mRNA vaccine encoding the RSV PreF protein.
  • To optimize the mRNA sequence for enhanced stability and translational efficiency.
  • To evaluate the immunogenicity and potential safety of the developed RSV mRNA vaccine.

Main Methods:

  • In silico analysis and Natural Language Processing (NLP) algorithms for mRNA sequence optimization.
  • In vitro and in vivo assays to assess mRNA stability and translational efficacy.
  • Immunogenicity studies in a BALB/c mouse model, including antibody and T-cell response analysis.

Main Results:

  • Optimized mRNA constructs demonstrated improved stability and translational efficacy.
  • The vaccine candidate elicited a balanced, Th1-biased immune response in mice.
  • High levels of neutralizing antibodies and robust T-cell immunity, including memory cell proliferation, were observed.

Conclusions:

  • A novel RSV PreF mRNA vaccine was successfully developed through protein structure and mRNA sequence optimization.
  • The vaccine demonstrated superior immunogenicity in a mouse model, with potential for safety and long-term immune memory.
  • These findings represent a significant advancement towards an effective RSV vaccine, warranting further investigation in challenge studies.